These studies suggest that Drp1-dependent mitochondrial fission and glycolytic metabolism are mutually reinforcing processes in tumor progression and that oncogenic gene-regulated metabolic reprogramming will result in changes in mitochondrial morphology to support metabolic alterations. The gene discussed is DNM1L; the disease is neoplasm.